Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMP2.1/AS01B Vaccine for Malaria
NCT02044198Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Mar 2014
- Primary completion
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of FMP2.1/AS01B in Plasmodium falciparum malaria, sponsored by University of Oxford. Started Mar 2014; status: completed.
02
Drugs
FMP2.1/AS01B
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02044198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044198.